Antonio Halais Frangieh

  • Citations Per Year
Learn More
The purpose of the study was to evaluate the optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention, especially in the era of second-generation drug-eluting stents (DES). The work was conducted from November 2014 to April 2015. All randomized controlled trials comparing short (<12 months) versus long (≥12 months) DAPT(More)
BACKGROUND Safety and efficacy of bioresorbable vascular scaffolds (BRS) and the role of postdilatation on outcome in acute coronary syndrome (ACS) patients compared with those of everolimus-eluting stents (EES) remain unknown. The aim of the study is to compare the safety and efficacy of BRS with EES in ACS and to investigate the role of BRS(More)
AIMS The safety and efficacy of rotational atherectomy (RA) in patients presenting with non-ST-elevation myocardial infarction (NSTE-ACS) remain to be defined. The aim of our study was to assess the safety and efficacy of RA in NSTE-ACS patients with reference to both short- and long-term follow-up. METHODS AND RESULTS This was an observational(More)
BACKGROUND ECG criteria differentiating Takotsubo cardiomyopathy (TTC) from mainly anterior myocardial infarction (MI) have been suggested; however, this was in small patient populations. METHODS AND RESULTS Twelve-lead admission ECGs of consecutive 200 TTC and 200 MI patients were compared in dichotomized groups based on the presence or absence of(More)
Circulation 2012;125:76–86. 25. Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D. Effect of 1-year anti-TNF-alpha therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. Am J Hypertens 2012;25: 644–650. 26. Brezinski EA, Follansbee MR, Armstrong EJ, Armstrong AW. Endothelial(More)
A 84-year-old female patient presented with recurrent right heart failure due to severe tricuspid regurgitation, enlarged right atrium (38 cm), and constrained right ventricular function (TAPSE 13 mm). The patient was judged too fragile for conventional surgery. Transoesophageal examination revealed severe tricuspid insufficiency between the posterior and(More)
AIMS Tricuspid regurgitation (TR) severity and right ventricular (RV) dysfunction have been identified as significant predictors of outcome after mitral valve surgery. The aim of the present study was to investigate the impact of percutaneous mitral valve repair (PMVR) with the MitraClip system on functional TR severity and RV function. METHODS AND(More)
BACKGROUND Limited data exist regarding transcatheter mitral valve replacement (TMVR) for patients with failed mitral valve replacement and repair. OBJECTIVES This study sought to evaluate the outcomes of TMVR in patients with failed mitral bioprosthetic valves (valve-in-valve [ViV]) and annuloplasty rings (valve-in-ring [ViR]). METHODS From the TMVR(More)
Bristol-Meyers Squibb, GlaxoSmithKline, March Sharp & DohmeChibret, Novartis, Pfizer, Sanofi, Serono, Servier, St Jude, Teva, Swiss Society of Hypertension, Swiss Heart Foudation, Swiss National Science Foundation and consultant fees from Bayer, Biogen, Boehringer Ingelheim, Bristol-Meyers Squibb, Genzyme, Merck Sharp & Dohme-Chibret, Novartis, Sanofi,(More)